Unclassified

[Articles] Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority

Although non-inferiority could not formally be concluded for either 100 mg or 300 mg of aspirin daily by comparison with 600 mg aspirin daily, there was evidence that the 100 mg dose had similar characteristics to 600 mg in terms of cancer risk but with fewer side-effects and les

Medical Literature · Updated 2026-08-10